共 50 条
- [21] A PHASE I TRIAL FOR THE USE OF INTRAVESICAL CABAZITAXEL, GEMCITABINE, AND CISPLATIN (CGC) IN THE TREATMENT OF BCG-REFRACTORY NON-MUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER [J]. JOURNAL OF UROLOGY, 2017, 197 (04): : E175 - E176
- [23] Phase II trial of gemcitabine, paclitaxel, and cisplatin in advanced transitional cell carcinoma. [J]. JOURNAL OF UROLOGY, 2005, 173 (04): : 360 - 360
- [26] A PHASE II TRIAL OF INTRAVESICAL GEMCITABINE AND DOCETAXEL (GEMDOCE) IN THE TREATMENT OF BCG-NA_IVE NON-MUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER [J]. JOURNAL OF UROLOGY, 2024, 211 (05): : E245 - E246